Search results 4
Digital博士論文障害者向け資料あり
National Diet Library
- Subject HeadingGastric cancer Ascites Progression-free survival Paclitaxel Ramucirumab
- Note (General)pdf Background:Ramucirumab has recently p......aclitaxel plus ramucirumab in patients wi......aclitaxel plus ramucirumab in patients wi......aclitaxel plus ramucirumab in patients wi......cies of common ramucirumab-related advers......paclitaxel and ramucirumab in patients wi......o the risks of ramucirumab-related toxicity in patients ...
Digital博士論文障害者向け資料あり
National Diet Library
- Subject Headingcost-effectiveness gastric cancer Markov model paclitaxel ramucirumab
- Note (General)...f paclitaxel + ramucirumab is a standard ......f paclitaxel + ramucirumab combination th......f paclitaxel + ramucirumab and paclitaxel......: Paclitaxel + ramucirumab combination th......ations: Adding ramucirumab to a regimen o......n the price of ramucirumab, as well as improves in other...
- Alternative Title...f Paclitaxel + Ramucirumab Combination Therapy for Advan...
Digital博士論文
Available onlineOther Libraries in Japan
- Summary, etc.Objectives: Ramucirumab, an anti-vascu......med to measure ramucirumab concentrations......C who received ramucirumab plus docetaxel......istration, the ramucirumab trough concent......o assess serum ramucirumab concentrations......ts with higher ramucirumab exposure had a......nts with lower ramucirumab exposure were ......osure level of ramucirumab in certain pat......al benefits of ramucirumab treatment.
- Subject Heading...armacokinetics Ramucirumab
Digital博士論文
Available onlineOther Libraries in Japan
- Summary, etc.Background: Ramucirumab has recently p......aclitaxel plus ramucirumab in patients wi......aclitaxel plus ramucirumab in patients wi......aclitaxel plus ramucirumab in patients wi......cies of common ramucirumab-related advers......paclitaxel and ramucirumab in patients wi......o the risks of ramucirumab-related toxicity in patients ...
- Subject HeadingGastric cancer Ascites Progression-free survival Paclitaxel Ramucirumab
Reached to the end of result.